Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Gavoille A, Kerbrat A, Edan G, Lepage E, Rollot F, Casey R, Mathey G, Stankoff B, Ciron J, de Seze J, et al.

Neurology. 2026 May 26; 106(10):e214943. PMID: 42085644. Abstract